West Pharmaceutical Services is a leading provider of innovative, high-quality injectable solutions and services.
For the first quarter of 2026, the company reported net sales of $844.9 million. Diluted earnings per share (EPS) was $1.92.
The company reported an operating cash flow of $89.9 million and a free cash flow of $47.2 million. Due to a strong start, management increased its full-year 2026 net sales guidance to a range of $3.295 billion to $3.350 billion.
This article was generated with the assistance of AI technology and reviewed for accuracy. AlphaStreet may receive compensation from companies mentioned in this article. This content is for informational purposes only and should not be considered investment advice.